> More than 350 doctors and medical workers have caught COVID-19 in Indonesia despite being vaccinated with Sinovac<p>This vaccine is known to be less effective but omitting it from the title sure makes for a headline.
From the article:<p>>"The data shows they have the Delta variant (in Kudus) so it is no surprise that the breakthrough infection is higher than before, because, as we know, the majority of healthcare workers in Indonesia got Sinovac, and we still don’t know yet how effective it is in the real world against the Delta variant,” said Dicky Budiman, an epidemiologist at Australia's Griffith University.
I really worry about headlines like this. It can lead people to believe that the vaccine isn't worth getting because "SEE breakthrough!" Keeping the nuance in headlines for this matter is key for adoption.<p>One key unknown is whether the infection of those health workers was better/worse than the normal response post vaccine.<p>Breath through infections are expected. Vaccination isn't fool proof. The primary goal is herd immunity at the community level, and that those who do have a break through, their experience isn't nearly as bad without the vaccine.
Efficacy test of Sinovac show it has ~50% rate<p>[1] <a href="https://www.bbc.com/news/world-latin-america-55642648" rel="nofollow">https://www.bbc.com/news/world-latin-america-55642648</a>
Why is this surprising? Sinovac-CoronaVac is an inactivated virus vaccine and it is expected to have less protection against mutations.<p>mRNA vaccines have the instructions to build only the spike protein once inside the body, which is supposed to mutate less as it's a crucial protein for the virus to function properly.